Retrovirus vector-mediated insertional mutagenesis (IM) can lead to serious cancerous risks in gene therapy. Although multiple cases of IM-induced malignancies have been reported in clinical trials with gammaretroviral vectors, no evidence for malignancies has been reported with HIV-derived lentiviral vectors (LVs). However, the 2010 clinical trial for ß-thalassaemia had reported the clonal dominance of erythroblasts in one patient. This was caused by the LV integration into the HMGA2 gene locus and the up-regulation of HMGA2 protein by the formation of host-vector chimeric transcripts (Cavazzana-Calvo et al., 2010). The observed pattern of splicing in the HMGA2 locus, splice-in, is splicing from a host splice donor to a vector splice accep...
Lentiviruses stably integrate their genome into the host genome. Although this feature can be advant...
Nonintegrating lentiviral vectors present a means of reducing the risk of insertional mutagenesis in...
To make human immunodeficiency virus type 1 (HIV-1)-based vectors safer for use in the research and ...
Retroviral vectors have been successfully used in the clinic for the correction of inherited immunod...
Gene transfer vectors derived from murine oncoretroviruses or human lentiviruses are widely used in ...
The integration characteristics of retroviral (RV) vectorsincrease the probability of interfering wi...
Genotoxicity assays based on systemic vector injection into newborn tumor-prone Cdkn2a−/− and Cdkn2a...
Indiana University-Purdue University Indianapolis (IUPUI)Lentiviral vector mediated gene therapy has...
The capacity to integrate transgenes into the host cell genome makes retroviral vectors an interesti...
Gene therapy vectors based on the HIV-1 lentivirus are an attractive option for clinical applicatio...
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated intravenous d...
Gene transfer vectors derived from gamma-retroviruses or lentiviruses are currently used for the gen...
BACKGROUND: Circular forms of viral genomic DNA are generated during infection of cells with retrovi...
The inherent risks associated with vector insertion in gene therapy need to be carefully assessed. W...
Lentiviral vectors (LV) are attractive for permanent and effective gene therapy. However, integratio...
Lentiviruses stably integrate their genome into the host genome. Although this feature can be advant...
Nonintegrating lentiviral vectors present a means of reducing the risk of insertional mutagenesis in...
To make human immunodeficiency virus type 1 (HIV-1)-based vectors safer for use in the research and ...
Retroviral vectors have been successfully used in the clinic for the correction of inherited immunod...
Gene transfer vectors derived from murine oncoretroviruses or human lentiviruses are widely used in ...
The integration characteristics of retroviral (RV) vectorsincrease the probability of interfering wi...
Genotoxicity assays based on systemic vector injection into newborn tumor-prone Cdkn2a−/− and Cdkn2a...
Indiana University-Purdue University Indianapolis (IUPUI)Lentiviral vector mediated gene therapy has...
The capacity to integrate transgenes into the host cell genome makes retroviral vectors an interesti...
Gene therapy vectors based on the HIV-1 lentivirus are an attractive option for clinical applicatio...
We used NOD/SCID mice, also known as NRG, to assess the ability of lentivirus-mediated intravenous d...
Gene transfer vectors derived from gamma-retroviruses or lentiviruses are currently used for the gen...
BACKGROUND: Circular forms of viral genomic DNA are generated during infection of cells with retrovi...
The inherent risks associated with vector insertion in gene therapy need to be carefully assessed. W...
Lentiviral vectors (LV) are attractive for permanent and effective gene therapy. However, integratio...
Lentiviruses stably integrate their genome into the host genome. Although this feature can be advant...
Nonintegrating lentiviral vectors present a means of reducing the risk of insertional mutagenesis in...
To make human immunodeficiency virus type 1 (HIV-1)-based vectors safer for use in the research and ...